KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $2.9 million.

  • Bionano Genomics' Other Working Capital Changes rose 19262.45% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 12996.65%. This contributed to the annual value of -$4.7 million for FY2024, which is 19318.73% down from last year.
  • Latest data reveals that Bionano Genomics reported Other Working Capital Changes of $2.9 million as of Q3 2025, which was up 19262.45% from -$336000.0 recorded in Q2 2025.
  • Bionano Genomics' 5-year Other Working Capital Changes high stood at $9.6 million for Q3 2023, and its period low was -$3.1 million during Q3 2024.
  • Its 5-year average for Other Working Capital Changes is $373578.9, with a median of -$336000.0 in 2025.
  • As far as peak fluctuations go, Bionano Genomics' Other Working Capital Changes surged by 207924.53% in 2021, and later crashed by 136210.53% in 2023.
  • Over the past 5 years, Bionano Genomics' Other Working Capital Changes (Quarter) stood at -$748000.0 in 2021, then skyrocketed by 74.6% to -$190000.0 in 2022, then tumbled by 1362.11% to -$2.8 million in 2023, then surged by 99.96% to -$1000.0 in 2024, then soared by 290200.0% to $2.9 million in 2025.
  • Its Other Working Capital Changes was $2.9 million in Q3 2025, compared to -$336000.0 in Q2 2025 and -$330000.0 in Q1 2025.